Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 3/2012

01.09.2012 | Original Article

The role of toxicology interpretations in prevention of sudden death

verfasst von: Jennifer L. Pilgrim, Dimitri Gerostamoulos, Olaf H. Drummer

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Inappropriate combinations of pharmaceutical drugs are often detected in deaths reported to a coroner. However, the involvement of drug combinations in the cause of death can be overlooked in cases when significant natural disease or external injury is also present. This study examined pathology reports and coroner’s findings between January 2002 and December 2008. Cases that included exposure to a selection of serotonergic drugs were examined to determine the role of different death investigators in drug-associated deaths in Victoria, Australia. Of the 326 cases identified, the involvement of drugs in the death was discussed to some degree in 66% of cases. Recommendations by the coroner pertaining to death prevention were made in 12 cases (4%). In 16 cases (5%) the drugs were not mentioned in the findings, including at least 11 cases of probable major adverse drug interactions. Death investigations serve an important public health and safety role, however, the potential involvement of drugs in many cases is not always recognized.
Literatur
1.
Zurück zum Zitat Australian Bureau of Statistics. Drug-induced death, Australia, 1991–2001. Canberra, Australia (2003) Contract No. 3321.0.55.001. Australian Bureau of Statistics. Drug-induced death, Australia, 1991–2001. Canberra, Australia (2003) Contract No. 3321.0.55.001.
2.
Zurück zum Zitat Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.PubMedCrossRef Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.PubMedCrossRef
4.
5.
Zurück zum Zitat Curphey TJ. Role of the forensic pathologist in the medicolegal certification of modes of death. J Forensic Sci. 1968;13(2):163–76.PubMed Curphey TJ. Role of the forensic pathologist in the medicolegal certification of modes of death. J Forensic Sci. 1968;13(2):163–76.PubMed
6.
Zurück zum Zitat Vanezis P. The role of the pathologist in the investigation of unexpected death in infancy (cot death). Med Sci Law. 1981;21(2):119–20.PubMed Vanezis P. The role of the pathologist in the investigation of unexpected death in infancy (cot death). Med Sci Law. 1981;21(2):119–20.PubMed
7.
Zurück zum Zitat Manini AF, Nelson LS, Olsen D, Vlahov D, Hoffman RS. Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int. 2011;206(1–3):71–6.PubMedCrossRef Manini AF, Nelson LS, Olsen D, Vlahov D, Hoffman RS. Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int. 2011;206(1–3):71–6.PubMedCrossRef
8.
Zurück zum Zitat Bugeja L, Ranson D. Coroners’ recommendations: a lost opportunity. J Law Med. 2005;13(2):173–5.PubMed Bugeja L, Ranson D. Coroners’ recommendations: a lost opportunity. J Law Med. 2005;13(2):173–5.PubMed
9.
Zurück zum Zitat Studdert DM, Cordner SM. Impact of coronial investigations on manner and cause of death determinations in Australia, 2000–2007. Med J Aust. 2010;192(8):444–7.PubMed Studdert DM, Cordner SM. Impact of coronial investigations on manner and cause of death determinations in Australia, 2000–2007. Med J Aust. 2010;192(8):444–7.PubMed
10.
Zurück zum Zitat Brodie L, Bugeja L, Ibrahim JE. Coroners’ recommendations following fatal heavy vehicle crash investigations. Aust N Z J Psychiatry. 2010;34(2):136–41. Brodie L, Bugeja L, Ibrahim JE. Coroners’ recommendations following fatal heavy vehicle crash investigations. Aust N Z J Psychiatry. 2010;34(2):136–41.
11.
Zurück zum Zitat Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving serotonergic drugs. Forensic Sci Int. 2010;198(1–3):110–7.PubMedCrossRef Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving serotonergic drugs. Forensic Sci Int. 2010;198(1–3):110–7.PubMedCrossRef
12.
Zurück zum Zitat Department of Health and Ageing (DHA). Pharmaceutical benefits scheme expenditure and prescriptions twelve months to 30 June 2007. Department of Health and Ageing (DHA). Pharmaceutical benefits scheme expenditure and prescriptions twelve months to 30 June 2007.
13.
Zurück zum Zitat Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125(6):803–15.PubMedCrossRef Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125(6):803–15.PubMedCrossRef
14.
Zurück zum Zitat Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250(4):327–41.PubMedCrossRef Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250(4):327–41.PubMedCrossRef
15.
Zurück zum Zitat Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447–50.PubMedCrossRef Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447–50.PubMedCrossRef
16.
Zurück zum Zitat Eap CB, Bertschy G, Powell K, Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol. 1997;17(2):113–7.PubMedCrossRef Eap CB, Bertschy G, Powell K, Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol. 1997;17(2):113–7.PubMedCrossRef
17.
18.
Zurück zum Zitat Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome p450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2010;7(2):162–84.PubMedCrossRef Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome p450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2010;7(2):162–84.PubMedCrossRef
Metadaten
Titel
The role of toxicology interpretations in prevention of sudden death
verfasst von
Jennifer L. Pilgrim
Dimitri Gerostamoulos
Olaf H. Drummer
Publikationsdatum
01.09.2012
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 3/2012
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-011-9309-7

Weitere Artikel der Ausgabe 3/2012

Forensic Science, Medicine and Pathology 3/2012 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …